Ambiq Prices $31 Public Offering to Raise $81.7M with Upsize Option
Ambiq Micro announced pricing of its upsized offering of 2,679,600 common shares at $31.00 each, including 2,636,651 shares by the company and 42,949 by existing stockholders. The offering is expected to generate gross proceeds of $81.7 million and grants underwriters a 30-day option on 401,940 additional shares.
1. Upsized Public Offering Details
Ambiq Micro, Inc. has priced an upsized underwritten public offering of 2,679,600 shares of its common stock, of which 2,636,651 shares are being sold by the company and 42,949 shares by certain existing stockholders. The company expects to receive approximately $81.7 million in gross proceeds before deducting underwriting discounts, commissions and other offering expenses payable by Ambiq.
2. Underwriter Overallotment Option
Ambiq granted the underwriters a 30-day option to purchase up to an additional 401,940 shares of common stock at the same offering terms, less underwriting discounts and commissions. This option provides the underwriters with flexibility to cover any over-allotments and supports price stabilization efforts post-closing.
3. Lead Managers and Closing Conditions
BofA Securities and UBS Investment Bank are acting as joint lead book-running managers, with Needham & Company and Stifel as joint book-running managers. The offering is expected to close on January 26, 2026, subject to customary closing conditions and the effectiveness of the registration statement declared by the SEC on January 22, 2026.